What Are the Latest Chikungunya Disease Statistics for 2025?
Click to start listening
Synopsis
Chikungunya disease cases have surged in 2025 with over 4.4 lakh cases and 155 deaths reported worldwide. The WHO highlights the urgent need for enhanced disease surveillance and vector control to tackle this growing health threat, especially in regions previously unaffected by this mosquito-borne virus.
Key Takeaways
- Over 4.4 lakh chikungunya cases reported globally in 2025.
- 155 deaths associated with the disease.
- Major outbreaks noted in 40 countries.
- India is significantly affected with 30,876 suspected cases.
- Urgent need for strengthening disease surveillance.
New Delhi, Oct 4 (NationPress) The global count has surpassed 4.4 lakh suspected and confirmed chikungunya disease cases, with 155 fatalities reported from January through September 30, 2025, according to the World Health Organization (WHO).
The most recent outbreak report, covering 40 countries, indicates that chikungunya virus (CHIKV) disease has emerged in numerous nations, including some that had not seen significant case numbers recently.
From January 1 to September 30, 2025, a total of 4,45,271 suspected and confirmed cases of CHIKV and 155 deaths were recorded globally across 40 countries, including both locally acquired and travel-related cases, as per the WHO.
The Americas reported the highest incidence with 3,28,920 suspected and confirmed cases, followed by Europe, which noted 56,456 confirmed cases primarily from French overseas territories in the Indian Ocean. This region also accounted for 40 deaths.
In India, from January 1 to March 31, 2025, there were 30,876 suspected cases and 1,741 confirmed cases. The states with the highest confirmed cases were Maharashtra, Karnataka, and Tamil Nadu. Fortunately, no fatalities were reported, according to the WHO.
A recent study published in the British Medical Journal (BMJ Global Health) indicates that over 1.40 crore individuals globally might be at risk of chikungunya infection annually.
Researchers from the London School of Hygiene and Tropical Medicine conducted a global modeling study revealing that India may bear the brunt of chikungunya, potentially exposing 51 lakh people to the mosquito-borne virus each year.
Brazil and Indonesia are predicted to be the second and third most affected countries, with India and Brazil representing 48% of the global burden on healthcare systems and individuals.
The CHIKV disease, transmitted by Aedes mosquitoes, is prevalent in tropical and subtropical regions. Although the fatality rate is low, severe cases can arise, especially among vulnerable groups such as infants, the elderly, and individuals with pre-existing conditions.
While CHIKV is primarily spread by infected female mosquitoes, notably Aedes aegypti and Aedes albopictus, which also transmit dengue and Zika, the virus can be introduced to new areas by infected travelers, leading to local transmission.
The report emphasizes that risks are heightened in previously unaffected regions due to limited immunity, favorable conditions for mosquito breeding, insufficient surveillance, and increased human mobility and trade. Strengthening disease surveillance, enhancing vector control, and improving public health preparedness are essential for mitigating further transmission risks.
Point of View
It is crucial to highlight the rising threat of chikungunya in 2025. The alarming statistics provided by the WHO call for immediate action in public health strategies. We must advocate for enhanced surveillance and vector control measures to prevent further outbreaks and safeguard vulnerable populations across the nation.
NationPress
04/10/2025
Frequently Asked Questions
What is chikungunya?
Chikungunya is a viral disease transmitted by Aedes mosquitoes, characterized by fever and severe joint pain.
How is chikungunya transmitted?
Chikungunya is primarily transmitted through bites from infected female Aedes mosquitoes, mainly Aedes aegypti and Aedes albopictus.
What are the common symptoms of chikungunya?
Symptoms include fever, joint pain, headache, muscle pain, rash, and fatigue.
Is there a vaccine for chikungunya?
Currently, there is no specific vaccine for chikungunya, and prevention focuses on mosquito control.
What measures can be taken to prevent chikungunya?
Preventive measures include eliminating mosquito breeding sites, using insect repellents, and wearing protective clothing.
